Presented on Monday, June 7, 2021 by Dr. Jinoos Yazdany
In this session, we will review information collected by the COVID-19 Global Rheumatology Alliance to help guide rheumatology clinicians in assessing and treating patients with rheumatologic disease. We will review the management of COVID-19 in immunosuppressed patients as well as the use of immunomodulatory drugs for COVID-19.
At the end of this session, participants will be able to:
- Identify high level data generated by the COVID-19 Global Rheumatology Alliance
- Discuss the management of immunocompromised patients during the COVID-19 pandemic
- Review the use of immunomodulating drugs to treat COVID-19
- Medical Expert
This webinar is part of a series supported by unrestricted educational grants from CRA COVID-19 Response Webinar Series supporters.